Phase I and pharmacokinetic study of the novel VEGF-directed fusion protein, aflibercept, in combination with docetaxel in women with recurrent ovarian, fallopian tube, and primary peritoneal cancer
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: R. L. Coleman, A. Kamat, R. Iyer, V. Kundra, M. Garcia, R. B. Jaffe, A. K. Sood
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2980535814
